BusinessUpdated 1 hr ago
Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Continue reading on The Hindu
Read full story Hello Headlines links you to the original publisher for the full story.


